AzTrials
AzTrials

Dentine SensitivityNCT07596797

Evaluation of the Effect of the Gel on Sensitive Teeth

A study testing Desensitizing tooth gel in people with Dentine Sensitivity, run by Lacer S.A. at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this study is to learn if a tooth gel works to alleviate teeth hypersensitivity in adults. It will also learn about the safety of the product. The main question it aims to answer is: Does the tooth gel help to improve signs of teeth hypersensitivity? Researchers will compare before and after product use to… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Dentine Sensitivity
What is being tested?
Desensitizing tooth gel
Could I receive a placebo?
No, everyone receives an active treatment
How many people
31 participants
Where
1 siteSpain
Study dates
8 Jul 2024to 31 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy female and male subjects (no specific repartition)
  • Aged between 18 years old
  • Subjects with dentine hyperesthesia
  • Have a minimum of two hypersensitive teeth anterior to non-consecutive molars, with cervical erosion/abrasion or gingival recession, and with a grade greater than or equal to 1 on the verbal rating scale (VRS) after tactile simulation, and greater than or equal to 1 on the Schiff cold air sensitive scale at the beginning of the study.
  • Subjects certifying the truthfulness of the personal data disclosed to the investigator
  • Subjects able to understand the language used in the investigation canter and the information given by the investigator
Show all 12Show fewer
  • Subjects able to respect the instructions given by the investigator as well as able to respect the study constraints and specific requirements
  • The pharmacological therapy (except for the pharmacological therapy in the non-inclusion criteria) should be stable for at least one month without any changes expected or planned during the study
  • Commitment not to change the daily routine or the lifestyle
  • Subjects who have not been recently involved in any other similar study
  • Commitment not to use during the study period other products with the same effect of the tested product
  • Subjects informed about the test procedures and who have signed a consent form.

Who cannot join

  • Subjects participating or planning to participate in other clinical trials;
  • Subjects deprived of liberty by administrative or judicial decision or under guardianship;
  • Subjects who cannot be contacted in an emergency;
  • Subjects admitted to a health or social center;
  • Subjects planning hospitalization during the study;
  • Subjects who participated in a similar study without respecting an adequate washout period (used any desensitizing agents during the last three months);
Show all 12Show fewer
  • Subjects who have used anti sensitivity products in the 4 weeks prior to screening;
  • Subjects under pharmacological treatments that the investigator considers incompatible with the requirements of the study;
  • Subjects who have had active caries within 12 months or who are at risk of caries development (multiple dental restorations, crowns with compromised margin) per examiners discretion;
  • Subjects who have shown allergies or sensitivity to any component of the product;
  • Subject breastfeeding, pregnant or not willing to take the necessary precautions to avoid pregnancy during the study (for women of childbearing age).
  • Any tooth surface adjacent to those surfaces under investigation, which in the opinion of the investigator have any other condition that provides symptoms confusing with those of cervical dentin hypersensitivity.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • CLINICA CIURANA Centre Dental

    Barcelona

Other trials in Spain

About this study

Official title: Evaluation of the Efficacy of a Product for Oral Care in Use Test Under Dentist Control.

The goal of this study is to learn if a tooth gel works to alleviate teeth hypersensitivity in adults. It will also learn about the safety of the product.

The main question it aims to answer is:

  • Does the tooth gel help to improve signs of teeth hypersensitivity?

Researchers will compare before and after product use to see if it works to improve teeth sensitivity. Participants will:

  • Use assigned products daily for 14 days
  • Visit the clinic on the established days during 14 days for check-ups and evaluation
Being tested
Desensitizing tooth gel
Medical subject headings
Dentin Sensitivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Desensitizing tooth gelOther

    Desensitizing tooth gel was used 3 times a day after meals during 14 days

Study groups in NCT07596797
Study groupRoleWhat they receive
Desensitizing tooth gelExperimentalNot described
Receives: Other: Desensitizing tooth gel

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline in teeth sensitivity to cold air at 14 days.

    Change evaluated by VAS score scale from 0 to 3, where 0 means the absence of pain while 3 is the highest pain.

    Measured: From enrolment to the end of use at 14 days.

  2. Change from Baseline in teeth sensitivity to periodontal probe at 14 days

    Change evaluated by VAS score scale: from 0 to 10, where 0 means the absence of pain while 10 is the highest pain

    Measured: From enrolment to the end of use at 14 days.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2026
  2. Study start8 Jul 2024
  3. Primary completion31 Jul 2024
  4. Study completion31 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07596797
Sponsor's protocol ID
ES0000257/24
Status last verified
May 2026
First submitted
12 May 2026
Last updated
19 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Only summary of the results to support the publication will be shared. No complete study documents will be shared.

Questions about this trial

What is this clinical trial studying?

A study testing Desensitizing tooth gel in people with Dentine Sensitivity, run by Lacer S.A. at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline in teeth sensitivity to cold air at 14 days. (time frame: From enrolment to the end of use at 14 days.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in